Amlodipine And Atorvastatin Tablet, Film Coated
Product Images NDC 71335-3076

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amlodipine And Atorvastatin (NDC 71335-3076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Amlodipine Besylate And Atorvastatin Calcium 02)

Figure 1 (Amlodipine Besylate And Atorvastatin Calcium 02)
This text provides information about an event rate analysis with a P-value of 0.003, Hazard Ratio of 0.691, and a 95% Confidence Interval ranging from 0.54 to 0.88. The data seems to be related to the drug "Amlodipine" and includes measurements at specific time points over months.*
FDA Label Image

Figure 2 (Amlodipine Besylate And Atorvastatin Calcium 03)

FDA Label Image

Figure 3 (Amlodipine Besylate And Atorvastatin Calcium 04)

FDA Label Image

Figure 4 (Amlodipine Besylate And Atorvastatin Calcium 05)

Figure 4 (Amlodipine Besylate And Atorvastatin Calcium 05)
This text provides information on cumulative hazard percentages for Placebo and Atorvastatin. It includes the hazard ratio (HR) with its corresponding confidence interval and p-value. Additionally, it presents data on the time to the first primary endpoint over a four-year follow-up period.*
FDA Label Image

Figure 5 (Amlodipine Besylate And Atorvastatin Calcium 06)

Figure 5 (Amlodipine Besylate And Atorvastatin Calcium 06)
This text provides information on the percentage of subjects experiencing an event, specifically related to Atorvastatin in two different doses (10 mg and 80 mg). It also includes hazard ratio (HR) and confidence interval for the data, as well as the time to the first major cardiovascular endpoint in years.*
FDA Label Image

Amlodipine (Amlodipine)

FDA Label Image

Atorvastatin-glycol-solvate (Atorvastatin Glycol Solvate)

FDA Label Image

Label (Lbl713353076)

Label (Lbl713353076)
This is a package insert for Amlodipine and Atorvastatin tablets, each containing 10 mg of Amlodipine and 10 mg of Atorvastatin. The tablets should be stored at 20° to 25°C (68° to 77°F) with excursions permitted from 15° to 30°C (59° to 86°F). The usual dosage information can be accessed by scanning the Package Insert QR Code. It is advised to dispense the tablets in a tight, light-resistant container with a child-resistant closure. The tablets are for prescription use only and come in a pack of 30 tablets. The product was repackaged by Bryant Ranch Prepack, Inc. and manufactured by Apotex Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.